|
US3496179A
(en)
|
1967-10-11 |
1970-02-17 |
Pfizer & Co C |
2-amino-3,4-dihydroquinazolines
|
|
EP0629347B1
(en)
|
1992-01-23 |
1997-07-02 |
Morinaga Milk Industry Co., Ltd. |
Antibacterial agent and treatment of article therewith
|
|
US6025326A
(en)
*
|
1995-07-07 |
2000-02-15 |
Intrabiotics Pharmaceuticals, Inc. |
Compositions and methods for the prevention and treatment of oral mucositis
|
|
US5994306A
(en)
*
|
1995-11-22 |
1999-11-30 |
Intrabiotics Pharmaceuticals, Inc. |
Fine-tuned protegrins
|
|
JP3090125B2
(ja)
|
1997-08-26 |
2000-09-18 |
千寿製薬株式会社 |
ソフトコンタクトレンズ用の眼科用組成物、ソフトコンタクトレンズの濡れ増強方法およびテルペノイドの吸着抑制方法
|
|
ES2198139T3
(es)
|
1998-08-20 |
2004-01-16 |
The University Of North Carolina At Chapel Hill |
Compuestos de dibenzotiofeno y procedimientos de uso de los mismos.
|
|
US20040152664A1
(en)
|
1998-09-02 |
2004-08-05 |
Allergan, Inc. |
Prednisolone compositions
|
|
US6440964B1
(en)
|
1998-09-30 |
2002-08-27 |
Alcon Manufacturing, Ltd. |
Compositions and methods for treating ophthalmic and otic infections
|
|
US6482799B1
(en)
|
1999-05-25 |
2002-11-19 |
The Regents Of The University Of California |
Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
|
|
JP2001261674A
(ja)
|
2000-03-22 |
2001-09-26 |
Mitsui Chemicals Inc |
ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
|
|
FR2813080B1
(fr)
|
2000-08-17 |
2002-11-29 |
Stago Diagnostica |
Peptides anti-heparine
|
|
ATE454157T1
(de)
|
2000-11-08 |
2010-01-15 |
Fxs Ventures Llc |
L-histidin in ophthalmologischen lösungen
|
|
CA2434693A1
(en)
*
|
2001-01-18 |
2002-10-17 |
Genzyme Corporation |
Ionene polymers and their use as antimicrobial agents
|
|
WO2002100295A2
(en)
|
2001-03-08 |
2002-12-19 |
The Trustees Of The University Of Pennsylvania |
Facially amphiphilic polymers as anti-infective agents
|
|
US7629317B2
(en)
|
2001-03-29 |
2009-12-08 |
The University Of Chicago |
Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
|
|
AR034372A1
(es)
|
2001-06-08 |
2004-02-18 |
Novartis Ag |
Composiciones farmaceuticas
|
|
AU2002341566A1
(en)
*
|
2001-08-16 |
2003-04-01 |
Mucosal Therapeutics, Inc. |
Treatment and prevention of mucositis in cancer patients
|
|
AU2003231879A1
(en)
|
2002-05-28 |
2003-12-12 |
The Trustees Of The University Of Pennsylvania |
Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
|
|
WO2003106053A1
(en)
|
2002-06-13 |
2003-12-24 |
The Trustees Of The University Of Pennsylvania |
Methods, systems, and computer program products for simulating biomembranes using coarse grain models
|
|
WO2004046109A2
(en)
*
|
2002-11-19 |
2004-06-03 |
Genzyme Corporation |
Ionene oligomers and polymers
|
|
EP2471527A3
(en)
|
2003-03-17 |
2012-12-12 |
The Trustees Of The University Of Pennsylvania |
Facially amphiphillc polymers and oligomers and uses thereof
|
|
AU2003249114A1
(en)
|
2003-03-20 |
2004-10-11 |
Shiseido International France |
Cosmetic composition
|
|
US20040202687A1
(en)
|
2003-04-14 |
2004-10-14 |
Babu M.K. Manoj |
Ciprofloxacin formulations and methods of making and using the same
|
|
US20050059639A1
(en)
|
2003-09-11 |
2005-03-17 |
Wei Edward T. |
Ophthalmic compositions and method for treating eye discomfort and pain
|
|
US20050065091A1
(en)
|
2003-09-18 |
2005-03-24 |
Gholam Peyman |
Stabilized ocular solutions
|
|
KR20120107142A
(ko)
|
2004-01-23 |
2012-09-28 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
표면적으로 친양쪽성인 폴리아릴 및 폴리아릴알키닐 중합체와 올리고머, 그리고 이들의 용도
|
|
EP2380872B1
(en)
|
2004-06-15 |
2014-04-23 |
Cellceutix Corporation |
Polycationic compounds and uses thereof
|
|
EP1771183B1
(en)
|
2004-07-23 |
2014-09-03 |
The Trustees of The University of Pennsylvania |
Antimicrobial copolymers and uses thereof
|
|
JP2008531585A
(ja)
|
2005-02-25 |
2008-08-14 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
表面が両親媒性のポリマーおよびオリゴマー、それらの組成物そして癌治療方法におけるそれらの使用
|
|
PL1704860T3
(pl)
*
|
2005-03-24 |
2011-04-29 |
Rottapharm Biotech Srl |
Pochodne benzamidyny do leczenia i zapobiegania zapaleniu śluzówki
|
|
WO2006122162A2
(en)
*
|
2005-05-10 |
2006-11-16 |
The University Of Chicago |
Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
|
|
US7951829B2
(en)
*
|
2006-05-03 |
2011-05-31 |
Janssen Pharmaceutica Nv |
Benzimidazole modulators of VR1
|
|
JP2008137978A
(ja)
|
2006-12-05 |
2008-06-19 |
Canon Inc |
カルバゾール誘導体及びこれを用いた有機発光素子
|
|
US20090092574A1
(en)
*
|
2006-12-29 |
2009-04-09 |
Scott Richard W |
Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
|
|
WO2009061697A1
(en)
|
2007-11-09 |
2009-05-14 |
The Board Of Trustees Of The University Of Illinois |
Anticoagulant antagonist and hemophilia procoagulant
|
|
CA2732572A1
(en)
*
|
2008-07-28 |
2010-02-04 |
Polymedix, Inc. |
Anti-malarial compounds
|
|
TWI478915B
(zh)
*
|
2008-10-27 |
2015-04-01 |
Cellceutix Corp |
宿主防禦之合成模擬物及其用途
|
|
MX2011006160A
(es)
*
|
2008-12-10 |
2011-09-21 |
Polymedix Inc |
Moleculas antimicrobianas para tratar cepas resistentes a multiples farmacos y ampliamente resistentes a farmacos de mycobacterium.
|
|
UA110323C2
(en)
*
|
2009-06-04 |
2015-12-25 |
Promedior Inc |
Derivative of serum amyloid p and their receipt and application
|
|
WO2011084970A1
(en)
*
|
2010-01-07 |
2011-07-14 |
Polymedix Inc. |
Anti-heparin compounds
|
|
TW201208677A
(en)
*
|
2010-08-21 |
2012-03-01 |
Polymedix Inc |
Facially amphiphilic compounds, compositions, and uses thereof in treating cancer
|
|
DK2709619T3
(en)
*
|
2011-05-16 |
2018-01-15 |
Cellceutix Corp |
RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
|
|
EP2790510A4
(en)
*
|
2011-12-13 |
2015-11-25 |
Cellceutix Corp |
CYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THEM
|
|
KR20140129030A
(ko)
*
|
2012-01-18 |
2014-11-06 |
셀슈틱스 코포레이션 |
캔디다증 및 아스퍼질러스 감염을 치료하기 위한 화합물 및 방법
|
|
WO2014093225A2
(en)
*
|
2012-12-10 |
2014-06-19 |
Cellceutix Corporation |
Polycyclic compounds and methods of making and using the same
|
|
US20140171438A1
(en)
*
|
2012-12-10 |
2014-06-19 |
Cellceutix Corporation |
Hybrid Compounds And Methods Of Making And Using The Same
|
|
MX363678B
(es)
*
|
2013-05-28 |
2019-03-29 |
Morphochem Aktiengesellschaft Fuer Komb Torische Chemie |
Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
|
|
JP6047203B2
(ja)
*
|
2015-02-20 |
2016-12-21 |
セルセウティックス コーポレイション |
消化管の炎症性疾患の予防および／または治療のための宿主防御タンパク質（ｈｄｐ）模倣薬
|
